Results 241 to 250 of about 93,626 (282)
Immunomodulatory Strategies for Managing Viral Infections in Solid Organ Transplantation: Progress and Challenges. [PDF]
Elalouf A, Maoz H.
europepmc +1 more source
Generation of effector cells from T cell subsets [PDF]
Koszinowski, Ulrich H., Simon, M. M.
core
We report a rational design strategy for STING antagonists by dual covalent targeting of Cys292/309 in its C‐terminal domain, directly preventing functional oligomerization. Through covalent warhead repurposing, we identified P005091 and revealed its unique dual‐cysteine mechanism.
Yuxuan Zhao +23 more
wiley +1 more source
Immune evasion of multidrug-resistant bacteria: insights from lung innate immune cells and targeted therapies. [PDF]
Xu Y, Gao Y, Li Y, Pan L.
europepmc +1 more source
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård +19 more
wiley +1 more source
Complement and inflammasome crosstalk in chronic inflammation. [PDF]
Janžič L, Kouter K.
europepmc +1 more source
Bimodal modulation of nitric oxide in endothelial cells is achieved by light‐sensitive polymer nanoparticles. In dark, P3HT/PEDOT:PSS NPs boost intracellular ·NO, upregulate both endothelial and induced nitric oxide synthase, and drive a metabolic shift toward glycolysis.
Camilla Marzuoli +12 more
wiley +1 more source
Bactericidal membrane attack complex formation initiates at the new pole of E. coli. [PDF]
van 't Wout MFL +7 more
europepmc +1 more source
Glaucoma, a major cause of blindness, involves retinal ganglion cell (RGC) degeneration. This study shows growth hormone‐releasing hormone receptor (GHRHR) deficiency preserves RGC survival and restores vision, unlike activation which only aids survival.
Yan Tong +24 more
wiley +1 more source

